Amphastar Pharmaceuticals (AMPH) PT Raised to $18 at Jefferies
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- Tech stocks power S&P 500 to record high as oil prices, producer inflation ease
- Oil pares losses after reports Houthis attacked Saudi Aramco refinery
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
- After-Hours Movers: CSCO, COHR, HLIT, CBRS, STUB, ENS
- After-Hours Movers: CRWV, NBIS, SMCI, LITE, CAVA, HRB
- After-Hours Movers: P, RIOT, BW, RKLB, HIMS, UPWK
- After-Hours Movers: TEAM, NET, TWLO, DOCS, FROG, DV, TTD, ABNB, DKNG, SG, RKT
- After-Hours Stock Movers: WDC, SNDK, FIG, APP, HUBS, SOUN, DASH, XYZ, Z, FLNC
Amphastar Pharmaceuticals (AMPH) PT Raised to $19 at Piper Jaffray
March 25, 2015 6:58 AM EDTPiper Jaffray analyst David Amsellem reiterated an Overweight-rating and boosted his price target on Amphastar Pharmaceuticals (NASDAQ: AMPH) to $19.00 (from $16.00) following solid execution in Q4.
Amsellem commented, "Amphastar reported a 4Q14 net loss per share of ($0.03) on revenues of $56M, compared to the Street estimates of ($0.07) and... More
Amphastar Pharma (AMPH) Tops Q4 EPS by 7c
March 24, 2015 4:03 PM EDTAmphastar Pharma (NASDAQ: AMPH) reported Q4 EPS of ($0.03), $0.07 better than the analyst estimate of ($0.10). Revenue for the quarter came in at $55.9 million, versus $54.9 million reported last year.
For earnings history and earnings-related data on Amphastar Pharma (AMPH) click here.
... More